These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 35883644)

  • 21. Syzygium jambolanum and Cephalandra indica homeopathic preparations inhibit albumin glycation and protect erythrocytes: an in vitro study.
    Tupe RS; Kulkarni A; Adeshara K; Shaikh S; Shah N; Jadhav A
    Homeopathy; 2015 Jul; 104(3):197-204. PubMed ID: 26143453
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phagocytosis of Erythrocytes from Gaucher Patients Induces Phenotypic Modifications in Macrophages, Driving Them toward Gaucher Cells.
    Dupuis L; Chauvet M; Bourdelier E; Dussiot M; Belmatoug N; Le Van Kim C; Chêne A; Franco M
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35886988
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The amino-terminal domains of the ezrin, radixin, and moesin (ERM) proteins bind advanced glycation end products, an interaction that may play a role in the development of diabetic complications.
    McRobert EA; Gallicchio M; Jerums G; Cooper ME; Bach LA
    J Biol Chem; 2003 Jul; 278(28):25783-9. PubMed ID: 12734202
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of irreversibly glycated LDL in human vascular smooth muscle cells: lipid loading, oxidative and inflammatory stress.
    Sima AV; Botez GM; Stancu CS; Manea A; Raicu M; Simionescu M
    J Cell Mol Med; 2010 Dec; 14(12):2790-802. PubMed ID: 19818091
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship between plasma glycation with membrane modification, oxidative stress and expression of glucose trasporter-1 in type 2 diabetes patients with vascular complications.
    Adeshara KA; Diwan AG; Jagtap TR; Advani K; Siddiqui A; Tupe RS
    J Diabetes Complications; 2017 Feb; 31(2):439-448. PubMed ID: 27884659
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Advanced Glycation End Products and Diabetes Mellitus: Mechanisms and Perspectives.
    Khalid M; Petroianu G; Adem A
    Biomolecules; 2022 Apr; 12(4):. PubMed ID: 35454131
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A distinctive histidine residue is essential for in vivo glycation-inactivation of human CD59 transgenically expressed in mice erythrocytes: Implications for human diabetes complications.
    Sahoo R; Ghosh P; Chorev M; Halperin JA
    Am J Hematol; 2017 Nov; 92(11):1198-1203. PubMed ID: 28815695
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glycation amplifies lipoprotein(a)-induced alterations in the generation of fibrinolytic regulators from human vascular endothelial cells.
    Zhang J; Ren S; Shen GX
    Atherosclerosis; 2000 Jun; 150(2):299-308. PubMed ID: 10856522
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Advanced glycation end-products, measured as skin autofluorescence, associate with vascular stiffness in diabetic, pre-diabetic and normoglycemic individuals: a cross-sectional study.
    Birukov A; Cuadrat R; Polemiti E; Eichelmann F; Schulze MB
    Cardiovasc Diabetol; 2021 Jun; 20(1):110. PubMed ID: 34176469
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Advanced glycation endproducts alter functions and promote apoptosis in endothelial progenitor cells through receptor for advanced glycation endproducts mediate overpression of cell oxidant stress.
    Chen J; Song M; Yu S; Gao P; Yu Y; Wang H; Huang L
    Mol Cell Biochem; 2010 Feb; 335(1-2):137-46. PubMed ID: 19756958
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Caffeic acid attenuates the inflammatory stress induced by glycated LDL in human endothelial cells by mechanisms involving inhibition of AGE-receptor, oxidative, and endoplasmic reticulum stress.
    Toma L; Sanda GM; Niculescu LS; Deleanu M; Stancu CS; Sima AV
    Biofactors; 2017 Sep; 43(5):685-697. PubMed ID: 28753257
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Diabetes mellitus, oxidative stress and advanced glycation endproducts].
    Bonnefont-Rousselot D; Beaudeux JL; Thérond P; Peynet J; Legrand A; Delattre J
    Ann Pharm Fr; 2004 May; 62(3):147-57. PubMed ID: 15243348
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proteomic study of endothelial dysfunction induced by AGEs and its possible role in diabetic cardiovascular complications.
    Banarjee R; Sharma A; Bai S; Deshmukh A; Kulkarni M
    J Proteomics; 2018 Sep; 187():69-79. PubMed ID: 29935336
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Advanced Glycation End Products: Potential Mechanism and Therapeutic Target in Cardiovascular Complications under Diabetes.
    Yang P; Feng J; Peng Q; Liu X; Fan Z
    Oxid Med Cell Longev; 2019; 2019():9570616. PubMed ID: 31885827
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Etomidate deteriorates the toxicity of advanced glycation end products to human endothelial Eahy926 cells.
    Wang X; Jin A; An M; Ding Y; Tuo Y; Qiu Y
    J Toxicol Sci; 2014; 39(6):887-96. PubMed ID: 25421967
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of advanced glycation end-products in the development of coronary artery disease in patients with and without diabetes mellitus: a review.
    Fishman SL; Sonmez H; Basman C; Singh V; Poretsky L
    Mol Med; 2018 Nov; 24(1):59. PubMed ID: 30470170
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Erythrocyte deformability has no influence on the rate of erythrophagocytosis in vitro by autologous human monocytes/macrophages.
    Baerlocher GM; Schlappritzi E; Straub PW; Reinhart WH
    Br J Haematol; 1994 Mar; 86(3):629-34. PubMed ID: 8043446
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased adhesion of lymphoid cells to glycated proteins.
    Ivanov GI; Chaushev TA; Dakovska LN; Kyurkchiev SD
    Int J Biochem Cell Biol; 1999 Jul; 31(7):797-804. PubMed ID: 10467736
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Angiogenesis impairment by the NADPH oxidase-triggered oxidative stress at the bone-implant interface: Critical mechanisms and therapeutic targets for implant failure under hyperglycemic conditions in diabetes.
    Hu XF; Wang L; Xiang G; Lei W; Feng YF
    Acta Biomater; 2018 Jun; 73():470-487. PubMed ID: 29649637
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of glycation in human lens protein structure change.
    Ramalho JS; Marques C; Pereira PC; Mota MC
    Eur J Ophthalmol; 1996; 6(2):155-61. PubMed ID: 8823589
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.